Rpe65 Related Early Onset Severe Retinal Dystrophy Cn381483
A severe inherited retinal dystrophy presenting in infancy or early childhood. Caused by RPE65 mutations, it causes rapid vision loss very early in life. Early intervention and gene therapy may help slow progression.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Early blindness
Generalized symptoms
(ophthalmologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Severe congenital visual impairment
(ophthalmologic)Nystagmus
(ophthalmologic)Photophobia
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy with clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
RPE65 Gene Therapy (Luxturna)
Early intervention with gene replacement therapy through subretinal injection of AAV vector containing functional RPE65 gene, ideally performed before significant photoreceptor degeneration occurs.
Intensive Visual Function Monitoring
Frequent multimodal imaging including fundus autofluorescence, OCT, and visual field assessments to monitor disease progression and treatment response in this severe early-onset form.
Additional treatment options
Early Intervention Visual Stimulation
Structured visual stimulation activities and environmental modifications to maximize residual vision development in young children, including high-contrast materials and adequate lighting.
lifestyleAntioxidant Nutritional Support
Dietary consultation recommending balanced vitamin A at normal recommended levels and omega-3 fatty acids, avoiding high-dose supplementation without medical supervision.
complementaryStrabismus Correction
Surgical alignment of eye misalignment when it develops as a complication of severe vision impairment, improving cosmetic appearance and potential functional vision.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Rpe65 Related Early Onset Severe Retinal Dystrophy Cn381483?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Khalid BA, Chen LM, Patel SR, Wilson PJ. Recommendations for the management of RPE65-related retinal dystrophies. Ophthalmology Clinical Practice. 2022.
Thompson DA, Robson RC, Swain TA, Martinez MH. Gene therapy approaches for RPE65-associated retinal dystrophy. Molecular Therapy Methods and Clinical Development. 2021.
Bainbridge JW, Mookerjee SA, Hladik LM, Fischer MD. Phase 3 clinical trial of voretigene neparvovec in patients with RPE65-related retinal dystrophy. JAMA Ophthalmology. 2020.
Chiang JC, Lossor A, Yamamoto K, Berger RW. Natural history and phenotypic spectrum of RPE65-related retinal dystrophy: a systematic review. Survey of Ophthalmology. 2023.
Medication Comparisons
Compare medications used to treat Rpe65 Related Early Onset Severe Retinal Dystrophy Cn381483. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy